KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Cash & Equivalents (2016 - 2025)

HCA Healthcare (HCA) has disclosed Cash & Equivalents for 16 consecutive years, with $1.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 46.2% to $1.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 billion, a 46.2% decrease, with the full-year FY2025 number at $1.0 billion, down 46.2% from a year prior.
  • Cash & Equivalents was $1.0 billion for Q4 2025 at HCA Healthcare, up from $997.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $2.9 billion in Q3 2024 to a low of $493.0 million in Q2 2022.
  • A 5-year average of $1.2 billion and a median of $997.0 million in 2025 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: soared 224.13% in 2024, then tumbled 65.48% in 2025.
  • HCA Healthcare's Cash & Equivalents stood at $1.5 billion in 2021, then tumbled by 37.42% to $908.0 million in 2022, then rose by 2.97% to $935.0 million in 2023, then surged by 106.74% to $1.9 billion in 2024, then plummeted by 46.2% to $1.0 billion in 2025.
  • Per Business Quant, the three most recent readings for HCA's Cash & Equivalents are $1.0 billion (Q4 2025), $997.0 million (Q3 2025), and $939.0 million (Q2 2025).